Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Chritters, I know I should have sold at first news of

<< Previous

Bullboard Posts

Next >>

Post by Kobedog1on Oct 28, 2021 3:01pm

118 Views

Post# 34060221

Chritters, I know I should have sold at first news of

reverse split. No need to rub anything gleefully in my face.
Today I posted my decision to sell, simply sum up my thoughts for the day.

( My closing "beware" was for AngelaL . A warning. She is an old believer.

To be clear
Kobedog is NOT AngelaL

Chritters, you might develop some sense of worth for yourself.
It is juvenile to shout out " I warned you " to anyone on this board.

Take care. Stay away from Covid and antimaskers antivaxxers.
We all have these misled twits in each of our families.
Pray for America.
It is headed for a s...storm in 2024.

Kobe from Niagara

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles